Clinical Trials Sponsored by Astellas Pharma Canada, Inc.
Total 1236 results
-
Astellas Pharma IncCompletedKidney TransplantationBelgium, France, Germany, Italy, Spain, Greece, Switzerland, United Kingdom, Ireland, South Africa, Romania, Sweden, Russian Federation, Austria, Hungary, Poland, Portugal, Netherlands, Argentina, Czechia, Norway, Slovakia
-
Astellas Pharma IncCompletedLiver TransplantationKorea, Republic of
-
Astellas Pharma IncCompletedKIDNEY TRANSPLANTATIONItaly
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedFungemia | Fungal InfectionsChina
-
Astellas Pharma IncCompletedDe Novo Kidney TransplantationBelgium, France, Netherlands, Spain, Sweden, Austria, Italy, Germany, United Kingdom, Hungary, Poland, Czech Republic
-
Astellas Pharma IncCompletedOveractive BladderThailand
-
Astellas Pharma IncCompletedKidney TransplantationUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedDiarrhea-predominant Irritable Bowel SyndromeJapan
-
Astellas Pharma IncCompletedDiarrhea-predominant Irritable Bowel SyndromeJapan
-
Astellas Pharma IncCompletedHealthy | Urine Phosphorus ExcretionJapan
-
Astellas Pharma IncCompletedProstate Cancer | TumorsUnited States
-
Astellas Pharma IncCompletedPharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male SubjectsJapan
-
Astellas Pharma IncCompletedFunctional Dyspepsia | DyspepsiaJapan
-
Astellas Pharma IncCompletedIrritable Bowel SyndromeJapan
-
Astellas Pharma IncCompletedPost Operative PainJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedCandidemia | CandidiasisBelgium, France, Germany, Spain, United States, India, Canada, Brazil, Switzerland, Austria, Croatia, Netherlands, Poland, Czech Republic, United Kingdom
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedDermatitis, Atopic | Eczema, AtopicFrance, Germany, United Kingdom, Spain, Belgium, Netherlands, Finland, Poland, Ireland, Hungary, Denmark, Latvia
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedAtopic DermatitisAustralia, Belgium, Poland, Hungary, Portugal, Germany, Iceland, Malta
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Spain, Belarus, Belgium, Ukraine, Denmark, Greece, Russian Federation, Czech Republic, Netherlands, Germany, Hungary, Italy, Slovakia, Sweden, Norway
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedPatients With Traumatic Pain, Post-surgical Pain and Tooth Extract PainJapan
-
Astellas Pharma IncCompletedDermatitis, AtopicUnited Kingdom, Finland, Ireland, Canada, Latvia
-
Astellas Pharma IncCompletedUlcerative ColitisJapan
-
Astellas Pharma IncCompletedRheumatoid ArthritisJapan
-
Astellas Pharma IncCompletedCandidemia | Invasive Candidiasis | Esophageal Candidiasis | Oropharyngeal CandidiasisUnited States
-
Astellas Pharma IncCompletedCandidiasis, OralArgentina, South Africa, Brazil, Peru
-
Astellas Pharma IncCompletedSleep Initiation and Maintenance DisordersJapan
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Czech Republic, Poland, Hungary, Belgium, Germany
-
Astellas Pharma IncCompletedKidney TransplantationNetherlands
-
Astellas Pharma IncCompletedTransplantationNetherlands, Spain, Germany, United Kingdom, Poland, France
-
Astellas Pharma IncCompletedA Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male SubjectsHealthy | Pharmacokinetics of ASP2408Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1585United States
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of MirabegronNetherlands
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of MirabegronFrance
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Canada
-
Astellas Pharma IncTerminatedCastrate Resistant Prostate CancerBelgium, France, United Kingdom
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of Darexaban and MetabolitesFrance
-
Astellas Pharma IncCompletedKidney TransplantationUnited States, Canada
-
Astellas Pharma IncCompletedBreast CancerUnited States, Ireland, Belgium, Czech Republic, Germany, Poland, Russian Federation, United Kingdom
-
Astellas Pharma IncCompletedRenal ImpairmentUnited States
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of MirabegronFrance
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of MirabegronFrance
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States